BGB-3111-217

Completed

Zanubrutinib in Participants With Active Proliferative Lupus Nephritis

Beigene Study ID info

BGB-3111-217

ClinicalTrials.gov ID info

China Drug Trials ID info

CTR20202662

Study Overview

Sex: All

Age: 18 Years / 70 Years

No Study Documents

Study Overview

Sex: All

Age: 18 Years / 70 Years

No Study Documents